These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15615549)

  • 1. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
    Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
    J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging.
    Wyttenbach R; Gallino A; Alerci M; Mahler F; Cozzi L; Di Valentino M; Badimon JJ; Fuster V; Corti R
    Circulation; 2004 Aug; 110(9):1156-61. PubMed ID: 15326071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging.
    Wyttenbach R; Corti R; Alerci M; Cozzi L; Di Valentino M; Segatto JM; Badimon JJ; Fuster V; Gallino A
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):416-23. PubMed ID: 17689112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular brachytherapy in the femoropopliteal segment using 192Ir and 188Re.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    Cardiovasc Intervent Radiol; 2008; 31(4):698-708. PubMed ID: 18185955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study.
    Minar E; Pokrajac B; Ahmadi R; Maca T; Seitz W; Stümpflen A; Pötter R; Ehringer H
    Radiology; 1998 Jul; 208(1):173-9. PubMed ID: 9646810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions.
    Zehnder T; von Briel C; Baumgartner I; Triller J; Greiner R; Mahler F; Do DD
    J Endovasc Ther; 2003 Apr; 10(2):304-11. PubMed ID: 12877614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time.
    Diehm N; Silvestro A; Do DD; Greiner R; Triller J; Mahler F; Baumgartner I
    J Endovasc Ther; 2005 Dec; 12(6):723-30. PubMed ID: 16363902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses.
    Cotroneo AR; Pascali D; Iezzi R
    J Endovasc Ther; 2008 Jun; 15(3):283-91. PubMed ID: 18540701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.
    Minar E; Pokrajac B; Maca T; Ahmadi R; Fellner C; Mittlböck M; Seitz W; Wolfram R; Pötter R
    Circulation; 2000 Nov; 102(22):2694-9. PubMed ID: 11094034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study.
    Wolfram RM; Budinsky AC; Pokrajac B; Potter R; Minar E
    Radiology; 2006 Sep; 240(3):878-84. PubMed ID: 16926331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B; Pötter R; Maca T; Fellner C; Mittlböck M; Ahmadi R; Seitz W; Minar E
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):923-31. PubMed ID: 11072147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study.
    Pokrajac B; Pötter R; Wolfram RM; Budinsky AC; Kirisits C; Lileg B; Mendel H; Sabeti S; Schmid R; Minar E
    Radiother Oncol; 2005 Jan; 74(1):3-9. PubMed ID: 15683661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.
    Werk M; Langner S; Reinkensmeier B; Boettcher HF; Tepe G; Dietz U; Hosten N; Hamm B; Speck U; Ricke J
    Circulation; 2008 Sep; 118(13):1358-65. PubMed ID: 18779447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
    Laxdal E; Eide GE; Wirsching J; Jenssen GL; Jonung T; Pedersen G; Amundsen SR; Dregelid E; Aune S
    Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):410-7. PubMed ID: 15350565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis.
    Narayan K; Denton M; Das R; Bernshaw D; Rolfo A; van Dyk S; Mirakian A
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):238-43. PubMed ID: 16820271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial.
    Krueger K; Landwehr P; Bendel M; Nolte M; Stuetzer H; Bongartz R; Zaehringer M; Winnekendonk G; Gossmann A; Mueller RP; Lackner K
    Radiology; 2002 Aug; 224(2):519-28. PubMed ID: 12147851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External beam radiation to prevent restenosis after superficial femoral artery balloon angioplasty.
    Therasse E; Donath D; Lespérance J; Tardif JC; Guertin MC; Oliva VL; Soulez G
    Circulation; 2005 Jun; 111(24):3310-5. PubMed ID: 15956130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoropopliteal angioplasty. Factors influencing long-term success.
    Capek P; McLean GK; Berkowitz HD
    Circulation; 1991 Feb; 83(2 Suppl):I70-80. PubMed ID: 1825050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.